TipRanks
Go Ultimate55% OFF

Miji International Holdings Limited (1715) AI Stock Analysis

HK:1715

Miji International Holdings Limited

(HKEX:1715)

Select Model
Rating:45Neutral
Price Target:HKD 0.37â–¼(-2.40% Downside)
Action:reiterated
Date:08/17/26

The score is held down primarily by weak financial performance (persistent losses, margin deterioration, revenue decline, and ongoing cash burn), only partially offset by improving leverage and reduced cash outflow versus 2024. Technicals are neutral with mild short-term momentum but a weaker longer-term trend, while valuation is constrained by a negative P/E that reflects loss-making operations.

Positive Factors
Lower LeverageThe reduction in debt-to-equity indicates improved balance-sheet discipline and lowers financial leverage relative to the prior year. If maintained, this gives the company more flexibility to manage operating volatility, allocate capital, and reduce pressure from debt-related obligations.
Negative Factors
Persistent LossesSustained losses across the reported period indicate that the current business model is not producing reliable earnings. A net margin near negative 75% leaves little tolerance for execution setbacks and makes a durable recovery dependent on substantial operating improvement.

Miji International Holdings Limited (1715) vs. iShares MSCI Hong Kong ETF (EWH)

-40%-30%-20%-10%0%10%20%HK:1715-26.47%EWH+7.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
HKD 135.28M
Dividend Yield
―
Average Volume (3M)
685.27K
Price to Earnings (P/E)
-2.8
Beta (1Y)
0.14
Revenue Growth
15.42%
EPS Growth
29.14%
Country
Hong Kong
Employees
52
Sector
Consumer Cyclical
Sector Strength
61
Industry
Furnishings, Fixtures & Appliances

Miji International Holdings Limited Business Overview & Revenue Model

Company Description

AI Health Technology Limited, an investment holding company, engages in the research and development, manufacturing, and trading of kitchen appliances primarily in the People’s Republic of China. It provides radiant and induction hobs and stoves, and...

Miji International Holdings Limited Financial Statement Overview

Summary

Financial performance is weak: sustained losses with sharply deteriorated 2025 profitability (net margin ~-75%) alongside a material revenue decline (-22.9% YoY). Cash flow remains negative (FCF about -12.5M in 2025) despite improvement vs 2024, and while leverage improved (debt-to-equity ~0.79 vs ~1.44), returns remain deeply negative (ROE about -58.9%).

Income Statement

12Very Negative

Balance Sheet

38Negative

Cash Flow

22Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue66.44M47.40M91.89M84.37M88.19M143.87M
Gross Profit4.40M4.26M6.49M21.22M38.49M65.27M
EBITDA-38.57M-29.57M-27.22M-36.05M-30.94M-35.40M
Net Income-43.52M-35.56M-35.85M-49.32M-43.21M-44.35M
Balance Sheet
Total Assets103.86M146.75M137.47M165.74M193.80M190.72M
Cash, Cash Equivalents and Short-Term Investments50.51M27.09M2.30M33.95M11.36M32.35M
Total Debt39.50M46.22M60.74M71.40M79.92M32.92M
Total Liabilities64.36M87.06M95.08M107.53M113.90M66.58M
Stockholders Equity38.65M58.83M42.06M58.21M80.36M124.27M
Cash Flow
Free Cash Flow20.40M-12.47M-35.37M13.80M-76.70M-13.24M
Operating Cash Flow20.40M-12.47M-35.21M14.42M-75.93M-11.02M
Investing Cash Flow17.00K423.00K-101.00K-2,00015.03M6.67M
Financing Cash Flow-14.60M34.51M3.63M8.13M39.30M-10.74M

Miji International Holdings Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price0.38

Price Trends

50DMA0.40Negative
100DMA0.42Negative
200DMA0.45Negative

Market Momentum

MACD-0.00Negative
RSI44.13Neutral
STOCH76.47Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1715, the sentiment is Negative. The current price of 0.38 is below the 20-day moving average (MA) of 0.38, below the 50-day MA of 0.40, and below the 200-day MA of 0.45, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 44.13 is Neutral, neither overbought nor oversold. The STOCH value of 76.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1715.

Miji International Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

HK:1715 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:0300HK:030071OutperformHKD 785.08B13.0121.28%5.08%7.41%13.37%
HK:6690HK:669066NeutralHKD 208.69B11.1514.12%6.62%-3.85%-13.53%
HK:1373HK:137363NeutralHKD 449.19M10.065.15%8.35%-8.88%-4.52%
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
HK:0229HK:022951NeutralHKD 355.94M104.840.51%5.63%-3.83%-93.40%
HK:1691HK:169147NeutralHKD 5.99B17.298.56%―0.39%―
HK:1715HK:171545NeutralHKD 135.28M-2.77-89.30%―15.42%29.14%

* Consumer Cyclical Sector Average

Performance Comparison

-20%0%20%HK:1715HK:1373HK:0229HK:1691HK:6690HK:0300Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
HK:1715 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:1715Miji International Holdings Limited0.38-0.14-26.47%
HK:1373International Housewares Retail Co 0.64-0.09-12.05%
HK:0229Raymond Industrial Limited0.71-0.20-21.72%
HK:1691JS Global Lifestyle Company Limited1.75-0.01-0.57%
HK:6690Haier Smart Home Co., Ltd. Class H19.95-3.97-16.61%
HK:0300Midea Group Co. Ltd. Class H96.6518.2923.34%

Miji International Holdings Limited Corporate Events

AI Health Technology Corrects Substantial Shareholder Disclosure in Interim Results

Aug 27, 2026

AI Health Technology Limited has issued a supplemental announcement to its interim results for the six months ended 30 June 2026 to correct information on substantial shareholders’ interests. The company clarified that, as of that date, Starlig...

AI Health Technology Widens Interim Loss Despite Revenue Growth

Aug 26, 2026

AI Health Technology Limited reported a sharp increase in interim revenue to RMB42.97 million for the six months ended 30 June 2026, up from RMB23.94 million a year earlier. However, gross profit margins compressed from 10.0% to 5.9%, reflecting high...

AI Health Technology Warns of Wider Interim Loss on Higher Investment Costs

Aug 12, 2026

AI Health Technology Limited, incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange, operates health-related businesses supported by technology and is developing a comprehensive marketing solution system. The group has been in...

AI Health Technology Sets Board Meeting to Review Interim Results and Dividend

Aug 12, 2026

AI Health Technology Limited has scheduled a board meeting for 26 August 2026 to review and approve the unaudited consolidated interim results for the six months ended 30 June 2026. The board will also decide on the publication of these results and c...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 17, 2026